MSET — Mindset pharma Share News
0.000.00%
Last trade - 00:00HealthcareSpeculativeMicro Cap
- CA$74.96m
- CA$67.85m
- CA$3.91m
Brief: Reunion Neuroscience Files Lawsuit Against Mindset Pharma
Brief: Mindset Pharma announced Exclusive Licensing Agreement For Cybin To Acquire Intellectual Property Rights For Subset Of Co's Preclinical Compounds
Brief: Mindset Pharma Receives Scientific Advice From UK Regulator Facilitating Advancement Of Phase 1 First-In-Human Clinical Trial Plan
Brief: Mindset Pharma Enters Manufacturing Agreement With Leading CDMO To Produce Pharmaceutical Grade Batches Of Next-Generation Psilocybin Drug Candidate, Msp-1014
Brief: Mindset Pharma Announces Filing Of International Patent Application
Brief: Mindset Pharma Reports Fiscal Year 2021 Financial Results And Provides Corporate Update
Brief: Mindset Pharma Announces Inclusion In NYSE Listed Advisorshares Psychedelics Exchange Traded Fund (ETF)